Cargando…
Use of biologic agents and risk of tuberculosis in Brazil, a tuberculosis high-burden country
BACKGROUND: Brazil is a country with a high burden of tuberculosis (TB). The immunomodulatory effect of biological therapies is associated with an increased risk of infection. This study evaluated the frequency of TB infection in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS),...
Autores principales: | Chaer, Fernanda Gomes Gonçalves, de Lucena Valim, Juliana Miranda, Reis, Rogério Castro, Klautau, Giselle Burlamaqui, de Souza, Branca Dias Batista |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398615/ https://www.ncbi.nlm.nih.gov/pubmed/32788921 http://dx.doi.org/10.7573/dic.212598 |
Ejemplares similares
-
Switching of biological therapies in Brazilian patients with rheumatoid arthritis
por: de Lucena Valim, Juliana Miranda, et al.
Publicado: (2018) -
Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study
por: Klautau, Giselle Burlamaqui, et al.
Publicado: (2018) -
The Relative Lymphocyte Count is Lower when the Etiological Agent in Pott Disease is Successfully Isolated
por: Zanon, Igor de Barcellos, et al.
Publicado: (2023) -
Recent transmission of drug-resistant Mycobacterium tuberculosis in a prison population in southern Brazil
por: Reis, Ana Julia, et al.
Publicado: (2016) -
Tuberculosis in Brazil: one country, multiple realities
por: Cortez, Andreza Oliveira, et al.
Publicado: (2021)